Literature DB >> 15093875

Heart disease risk factors predict erectile dysfunction 25 years later: the Rancho Bernardo Study.

Maple M Fung1, Richele Bettencourt, Elizabeth Barrett-Connor.   

Abstract

OBJECTIVES: We examined whether common coronary heart disease (CHD) risk factors measured in mid-life predict erectile dysfunction (ED) 25 years later.
BACKGROUND: Retrospective and cross-sectional studies have suggested that ED is associated with classic CHD risk factors, but few prospective studies have studied these associations.
METHODS: In this prospective study of community-dwelling men age 30 to 69 years, seven classic CHD risk factors (age, smoking, hypertension, diabetes, hypercholesterolemia, hypertriglyceridemia, and obesity) were assessed from 1972 to 1974. In 1998, after an average follow-up of 25 years, surviving male participants were asked to complete the International Index of Erectile Function (IIEF-5), which allows stratification of ED into five groups.
RESULTS: Sixty-eight percent of the surviving men returned, and 60% completed the IIEF-5 questionnaire. Respondents had more favorable levels of all heart disease risk factors at baseline than non-respondents. At baseline, the average age of the 570 ED study participants was 46 years; at follow-up, their average age was 72 years. Mean age, body mass index, cholesterol, and triglycerides were each significantly associated with an increased risk of ED. Cigarette smoking was marginally more common in those with severe/complete ED, as compared with those without ED. Blood pressure and fasting blood glucose were not significantly associated with ED, likely due to selective mortality.
CONCLUSIONS: Improving CHD risk factors in mid-life may decrease the risk of ED as well as CHD. Erectile dysfunction should be included as an outcome in clinical trials of lipid-lowering agents and lifestyle modifications.

Entities:  

Mesh:

Year:  2004        PMID: 15093875     DOI: 10.1016/j.jacc.2003.11.041

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  52 in total

1.  Erectile dysfunction among hemodialysis patients.

Authors:  Ali Reza Makarem; Mohammad Yasin Karami; Omid Reza Zekavat
Journal:  Int Urol Nephrol       Date:  2010-06-11       Impact factor: 2.370

Review 2.  Lose weight to lose erectile dysfunction.

Authors:  Michael F Evans
Journal:  Can Fam Physician       Date:  2005-01       Impact factor: 3.275

3.  Occurrence of erectile dysfunction, testosterone deficiency syndrome and metabolic syndrome in patients with abdominal obesity. Where is a sufficient level of testosterone?

Authors:  Juraj Fillo; Jan Breza; Michaela Levčíkova; Jan Luha; Anna Vachulova; Štefan Durdík; Peter Labaš
Journal:  Int Urol Nephrol       Date:  2012-08       Impact factor: 2.370

4.  Small-vessel lower extremity arterial disease and erectile dysfunction: The Rancho Bernardo study.

Authors:  Shua J Chai; Elizabeth Barrett-Connor; Anthony Gamst
Journal:  Atherosclerosis       Date:  2008-08-07       Impact factor: 5.162

Review 5.  What do most erectile dysfunction guidelines have in common? No evidence-based discussion or recommendation of heart-healthy lifestyle changes and/or Panax ginseng.

Authors:  Mark A Moyad; Kwangsung Park
Journal:  Asian J Androl       Date:  2012-09-24       Impact factor: 3.285

6.  Cardiorenal Determinants of Erectile Dysfunction in Primary Prevention: A Cross-Sectional Study.

Authors:  Vilma Dzenkeviciute; Zaneta Petrulioniene; Egidija Rinkuniene; Virginijus Sapoka; Marija Petrylaite; Jolita Badariene
Journal:  Med Princ Pract       Date:  2017-11-05       Impact factor: 1.927

Review 7.  From inflammation to sexual dysfunctions: a journey through diabetes, obesity, and metabolic syndrome.

Authors:  M I Maiorino; G Bellastella; D Giugliano; K Esposito
Journal:  J Endocrinol Invest       Date:  2018-03-16       Impact factor: 4.256

8.  Cardiovascular disease risk, vascular health and erectile dysfunction among middle-aged, clinically depressed men.

Authors:  B M Hoffman; A Sherwood; P J Smith; M A Babyak; P M Doraiswamy; A Hinderliter; J A Blumenthal
Journal:  Int J Impot Res       Date:  2009-09-24       Impact factor: 2.896

Review 9.  Erectile dysfunction and cardiovascular disease: efficacy and safety of phosphodiesterase type 5 inhibitors in men with both conditions.

Authors:  Ajay Nehra
Journal:  Mayo Clin Proc       Date:  2009-02       Impact factor: 7.616

Review 10.  Microvascular complications in diabetic erectile dysfunction: do we need other alternatives?

Authors:  Yoram Vardi
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.